Lorvotuzumab mertansine Uses, Dosage, Side Effects and more
Lorvotuzumab mertansine has been used in trials studying the treatment of SCLC, Leukemia, Ovarian Cancer, Multiple Myeloma, and Merkel Cell Carcinoma, among others.
| Attribute | Details |
|---|---|
| Trade Name | Lorvotuzumab mertansine |
| Generic | Lorvotuzumab mertansine |
| Lorvotuzumab mertansine Other Names | Lorvotuzumab mertansine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
